The PTB domain: The name doesn't say it all

Trends in Endocrinology and Metabolism

Volumn 10, Issue 7, 1999, Pages 262-267

  Margolis, Ben ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN; NITRIC OXIDE SYNTHASE; PHOSPHOTYROSINE; PROTEIN TYROSINE KINASE; RECEPTOR PROTEIN;

CELL FUNCTION; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032781173     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(99)00168-X     Document Type: Review

References (57)

1. Blaikie P.et al. A region in Shc distinct from the SH2 domain can bind tyrosine phosphorylated growth factor receptors. J. Biol. Chem. 269:1994;32031-32034.
2. Kavanaugh W.M., Williams L.T. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science. 266:1994;1862-1865.
3. Gustafson T.A.et al. Phosphotyrosine-dependent interaction of Shc and IRS-1 with the NPEY motif of the insulin receptor via a novel (non-SH2) domain. Mol. Cell. Biol. 15:1995;2500-2508.
4. Sun X.J.et al. Role of IRS-2 in insulin and cytokine signalling. Nature. 377:1995;173-177.
5. Batzer A.G.et al. The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor. Mol. Cell. Biol. 15:1995;4403-4409.
6. Kavanaugh W.M., Turck C.W., Williams L.T. PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine. Science. 268:1995;1177-1179.
7. Trub T.et al. Specificity of the PTB domain of Shc for beta turn-forming pentapeptide motifs amino-terminal to phosphotyrosine. J. Biol. Chem. 270:1995;18205-18208.
8. Zhou M.M.et al. Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Nature. 378:1995;584-592.
9. Lemmon M.A., Ferguson K.M. Pleckstrin homology domains. Curr. Top. Microbiol. Immunol. 228:1998;39-74.
10. Ravichandran K.S.et al. Evidence for a requirement for both phospholipid and phosphotyrosine binding via the Shc phosphotyrosine-binding domain in vivo. Mol. Cell. Biol. 17:1997;5540-5549.
11. Okamoto M., Sudhof T.C. Mints, Munc18-interacting proteins in synaptic vesicle exocytosis. J. Biol. Chem. 272:1997;31459-31464.
12. Takeuchi H.et al. PTB domain of insulin receptor substrate-1 binds inositol compounds. Biochem. J. 334:1998;211-218.
13. Lu B., Rothenberg M., Jan L.Y., Jan Y.N. Partner of Numb colocalizes with Numb during mitosis and directs Numb asymmetric localization in Drosophila neural and muscle progenitors. Cell. 95:1998;225-235.
14. Yaich L.et al. Functional analysis of the numb phosphotyrosine binding domain using site directed mutagenesis. J. Biol. Chem. 273:1998;10381-10388.
15. White M.F. The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol. Cell. Biochem. 182:1998;3-11.
16. Wolf G.et al. PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities. J. Biol. Chem. 270:1995;27407-27410.
17. Eck M.J.et al. Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell. 85:1996;695-705.
18. Zhou M.M.et al. Structural basis for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain. Nat. Struct. Biol. 3:1996;388-393.
19. Mandiyan V.et al. Thermodynamic studies of SHC phosphotyrosine interaction domain recognition of the NPXpY motif. J. Biol. Chem. 271:1996;4770-4775.
20. Farooq A., Plotnikova O., Zeng L., Zhou M.M. Phosphotyrosine binding domains of Shc and insulin receptor substrate 1 recognize the NPXpY motif in a thermodynamically distinct manner. J. Biol. Chem. 274:1999;6114-6121.
21. Yamanashi Y., Baltimore D. Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok. Cell. 88:1997;205-211.
22. Carpino N.et al. p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell. 88:1997;197-204.
23. Kouhara H.et al. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell. 89:1997;693-702.
24. Fiore F.et al. The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein. J. Biol. Chem. 270:1995;30853-30856.
25. Borg J.P., Ooi J., Levy E., Margolis B. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol. Cell. Biol. 16:1996;6229-6241.
26. Zhang Z.et al. Sequence-specific recognition of the internalization motif of the Alzheimer's amyloid precursor protein by the X11 PTB domain. EMBO J. 16:1997;6141-6150.
27. Dho S.E.et al. The mammalian numb phosphotyrosine-binding domain. Characterization of binding specificity and identification of a novel PDZ domain-containing numb binding protein, LNX. J. Biol. Chem. 273:1998;9179-9187.
28. Charest A.et al. Phosphotyrosine-independent binding of SHC to the NPLH sequence of murine protein-tyrosine phosphatase-PEST. Evidence for extended phosphotyrosine binding/phosphotyrosine interaction domain recognition specificity. J. Biol. Chem. 271:1996;8424-8429.
29. Trommsdorff M., Borg J.P., Margolis B., Herz J. Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J. Biol. Chem. 273:1998;33556-33560.
30. Chien C.T.et al. Numb-associated kinase interacts with the phosphotyrosine binding domain of Numb and antagonizes the function of Numb in vivo. Mol. Cell. Biol. 18:1998;598-607.
31. Li S.C.et al. High-affinity binding of the Drosophila Numb phosphotyrosine-binding domain to peptides containing a Gly-Pro-(p)Tyr motif. Proc. Natl. Acad. Sci. U. S. A. 94:1997;7204-7209.
32. Li S.C.et al. Structure of a Numb PTB domain-peptide complex suggests a basis for diverse binding specificity. Nat. Struct. Biol. 5:1998;1075-1083.
33. Chervitz S.A.et al. Comparison of the complete protein sets of worm and yeast: orthology and divergence. Science. 282:1998;2022-2028.
34. Borg J.P., Margolis B. Function of PTB domains. Curr. Top. Microbiol. Immunol. 228:1998;23-38.
35. Fanning A.S., Anderson J.M. PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. J. Clin. Invest. 103:1999;767-772.
36. Borg J.P.et al. The phosphotyrosine binding domain protein X11α slows cellular amyloid precursor protein processing and reduces APPs, Aβ40 and Aβ42 secretion. J. Biol. Chem. 273:1998;14761-14766.
37. Tomita S.et al. Interaction of a neuron-specific protein containing PDZ domains with Alzheimer's amyloid precursor protein. J. Biol. Chem. 274:1999;2243-2254.
38. Sastre M., Turner R.S., Levy E. X11 interaction with beta-amyloid precursor protein modulates its cellular stabilization and reduces amyloid beta-protein secretion. J. Biol. Chem. 273:1998;22351-22357.
39. Kaech S.M., Whitfield C.W., Kim S.K. The LIN-2/LIN-7/LIN-10 complex mediates basolateral membrane localization of the C. elegans EGF receptor LET-23 in vulval epithelial cells. Cell. 94:1998;761-771.
40. Rongo C.et al. LIN-10 is a shared component of the polarized protein localization pathways in neurons and epithelia. Cell. 94:1998;751-759.
41. Hata Y., Butz S., Sudhof T.C. CASK: a novel dlg/PSD95 homolog with an N-terminal calmodulin-dependent protein kinase domain identified by interaction with neurexins. J. Neurosci. 16:1996;2488-2494.
42. Simske J.S., Kaech S.M., Harp S.A., Kim S.K. LET-23 receptor localization by the cell junction protein LIN-7 during C. elegans vulval induction. Cell. 85:1996;195-204.
43. Butz S., Okamoto M., Sudhof T.C. A tripartite protein complex with the potential to couple synaptic vesicle exocytosis to cell adhesion in brain. Cell. 94:1998;773-782.
44. Borg J.P.et al. Identification of an evolutionarily conserved heterotrimeric protein complex involved in protein targeting. J. Biol. Chem. 273:1998;31633-31636.
45. Gertler F.B., Hill K.K., Clark M.J., Hoffmann F.M. Dosage-sensitive modifiers of Drosophila abl tyrosine kinase function: prospero, a regulator of axonal outgrowth, and disabled, a novel tyrosine kinase substrate. Genes Dev. 7:1993;441-453.
46. Sheldon M.et al. Scrambler and yotari disrupt the disabled gene and produce a reeler-like phenotype in mice. Nature. 389:1997;730-733.
47. Howell B.W., Hawkes R., Soriano P., Cooper J.A. Neuronal position in the developing brain is regulated by mouse disabled-1. Nature. 389:1997;733-737.
48. D'Arcangelo G.et al. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature. 374:1995;719-723.
49. Rice D.S.et al. Disabled-1 acts downstream of Reelin in a signaling pathway that controls laminar organization in the mammalian brain. Development. 125:1998;3719-3729.
50. Le N., Simon M.A. Disabled is a putative adaptor protein that functions during signaling by the sevenless receptor tyrosine kinase. Mol. Cell. Biol. 18:1998;4844-4854.
51. Roses A.D. The Alzheimer diseases. Curr. Opin. Neurobiol. 6:1996;644-650.
52. Sabo S.L.et al. Regulation of beta-amyloid secretion by FE65, an amyloid protein precursor-binding protein. J. Biol. Chem. 274:1999;7952-7957.
53. Whitmarsh A.J.et al. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science. 281:1998;1671-1674.
54. Jaffrey S.R.et al. CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95. Neuron. 20:1998;115-124.
55. Liu Q.A., Hengartner M.O. Candidate adaptor protein CED-6 promotes the engulfment of apoptotic cells in C. elegans. Cell. 93:1998;961-972.
56. Snow B.E.et al. GTPase activating specificity of RGS12 and binding specificity of an alternatively spliced PDZ (PSD-95/Dlg/ZO-1) domain. J. Biol. Chem. 273:1998;17749-17755.
57. Ermekova K.S.et al. The WW domain of neural protein FE65 inter-acts with proline-rich motifs in Mena, the mammalian homolog of Drosophila enabled. J. Biol. Chem. 272:1997;32869-32877.